Open AccessComparison of Vildagliptin and Rosiglitazone Monotherapy in Patients With Type 2 Diabetes
Author(s) -
Julio Rosenstock,
Michelle A. Baron,
S. Dejager,
David Mills,
Anja Schweizer
Publication year - 2007
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc06-1815
Subject(s) - vildagliptin , rosiglitazone , medicine , tolerability , type 2 diabetes , diabetes mellitus , endocrinology , adverse effect
To compare the efficacy and tolerability of vildagliptin and rosiglitazone during a 24-week treatment in drug-naïve patients with type 2 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom